Suppr超能文献

磺胺甲噁唑-甲氧苄啶对荚膜组织胞浆菌荚膜变种的体外作用。

In vitro effect of sulfamethoxazole-trimethoprim against Histoplasma capsulatum var. capsulatum.

机构信息

Specialized Medical Mycology Center, Postgraduate Program in Medical Microbiology, Federal University of Ceará, Fortaleza, Ceará, Brazil.

出版信息

Antimicrob Agents Chemother. 2010 Sep;54(9):3978-9. doi: 10.1128/AAC.00793-10. Epub 2010 Jun 21.

Abstract

This study evaluated the in vitro effect of sulfamethoxazole-trimethoprim against Histoplasma capsulatum var. capsulatum isolated from HIV-positive patients. The drugs were tested by microdilution testing in accordance with the CLSI guidelines. All of the strains were inhibited by sulfamethoxazole-trimethoprim, with MIC ranges of 0.039 (sulfamethoxazole)/0.0078 (trimethoprim) mg/ml to 0.625/0.125 mg/ml for mycelial forms and 0.0025/0.0005 to 0.02/0.004 mg/ml for yeast-like forms. However, in vivo studies are necessary to evaluate the significance of these results.

摘要

本研究评估了磺胺甲恶唑-甲氧苄啶对分离自 HIV 阳性患者的荚膜组织胞浆菌的体外作用。根据 CLSI 指南,采用微量稀释法进行药物测试。所有菌株均被磺胺甲恶唑-甲氧苄啶抑制,其菌丝体 MIC 范围为 0.039(磺胺甲恶唑)/0.0078(甲氧苄啶)mg/ml 至 0.625/0.125mg/ml,酵母样形式为 0.0025/0.0005 至 0.02/0.004mg/ml。然而,需要进行体内研究来评估这些结果的意义。

相似文献

引用本文的文献

9
Antifungal therapeutics for dimorphic fungal pathogens.用于双相真菌病原体的抗真菌治疗药物。
Virulence. 2017 Feb 17;8(2):211-221. doi: 10.1080/21505594.2016.1235653. Epub 2016 Sep 19.

本文引用的文献

1
[Histoplasmosis].[组织胞浆菌病]
Rev Soc Bras Med Trop. 2009 Mar-Apr;42(2):192-8. doi: 10.1590/s0037-86822009000200020.
6
Histoplasmosis: a clinical and laboratory update.组织胞浆菌病:临床与实验室最新进展
Clin Microbiol Rev. 2007 Jan;20(1):115-32. doi: 10.1128/CMR.00027-06.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验